The analyses of monocytes subpopulations including classical (CD14+CD16-), inflammatory (CD14+CD16+) and transitory (CD14lowCD16+) monocytes suggested that the percentage of inflammatory monocytes was significantly increased in COVID-19 patients compared to healthy donors (Figure 5A). Here, CD14 is linked to COVID-19.